Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Esophageal Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China
Contact: Study coordinator (Shao-bin Chen) · chensb535176@hotmail.com · +8613417000759

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma

Esophageal Squamous Cell Carcinoma (ESCC)

Abroad (travel likely)RecruitingPHASE2

Annecy, France · Amiens, France

A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)

Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Beijing, China

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

NSCLC (Advanced Non-small Cell Lung Cancer) · HNSCC · CRC (Colorectal Cancer)

Abroad (travel likely)RecruitingPHASE1

Tampa, United States · Farmington Hills, United States

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Carcinoma, Non-Small-Cell Lung · Squamous Cell Carcinoma of the Head and Neck · Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Birmingham, United States